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The 180-kDa bullous pemphigoid antigen (BPAG2) is 
a c a n didate g ene/protein for mutations in some forms 
of junctional epidermolysis bullosa. In this study, we 
searched for Inutations in BPAG2 in a large Austrian 
pedigree with generalized atrophic benign epidermol-
ysis bullosa, a distinct nonlethal form. of junctional 
epidermolysis bullosa, using polymerase chain reaction 
atnplification of genomic DNA, heteroduplex analysis 
of t he polymerase chain reaction products, and direct 
nucleotide sequencing. We identified a homozygous 
T he hemidesmosome-anchoring ft h1l11cnt complex consists o f se veral prote ins, includ illg the 230- kDa and the 180-kDa bullous pemphi goid antigens (BPAG 1. BPAG2, respective ly), the basa l keratino-cyte a6{34 integnn , and th e anchoring fdament pro-
tein, la111i11in 5 (Ui tto and C hristiano, 1992; Yancey, 1995) . 
Imm unoflu orescence analyses with antibodies to some o f these 
components in patien ts wi th junctio nal epidermolys is bullosa OEB) 
have dem onstrated altered patte rn s, implicating severa l candidate 
genes fo r mutations ill di fferent forms of this discase (Schofield el ai, 
1990; Fine el ai, 1991 ) . Specific mutations in J EB indi viduals h ave 
subsequently been delineated in the three gen es that encode 
laminin 5 (LAM A3, LAMB3 , and LAM C2) (Aberdam el ai, 1994; 
Pulkkin en c/ ai, 1994a, 1994b; Ui tto cl al. 1994; K ivirik ko el ai, 
1995), and in the {34 integrin gene (ITGB4) (Vidal el ai, 199 5). 
Generalized atrophic benign epidermolys is bullosa (GABEB) is a 
subtype of nonlethal JEB, ch aracterized by skin fragiJi ty, atrophic 
alopecia, dysp lastic teeth, and nail dystrophy (Hashimoto el ai, 
1976; Schnyder and Anton-Lam prech t, 1979 ; Hintner and W olff. 
1982). ImmllnoAu orcscent antibody staining of the skin of several 
individuals with GABEB has reveal ed reduced cxpressio n of th c 
180- kD a bullo us pcmphigoid antigcn Oonkman cl ai, 1995). In 
addition , we have recently demonstrated com pound hetcrozygous 
premature ternunation codon m utations in the BPAG2 gene in a 
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2-bp deletion within the coding region ofBPAG2 in the 
a ffected individuals. This muta tion results in a frame-
shift and dowllstr eam stop co dons on both allele s, 
predicting an absence of functional protein. T hese 
findings illustrate the mole cular basis of the skin fragil-
ity in this fatnily and attest to the itnportance of the 
180-kDa bullous pemphigoid antigen in the a t tachment 
of the epidermis to the underlying dermoepidermal 
basement m entbrane.] Illvest D el'llw.tol 106:771-774, 1996 
patien t w ith clinica l features of GABEB (M cG rath el ai, 1995a), thus 
highlighting the m o lecular heterogeneity of J EB . 
In 1982 , H.in tller and Wolff described a large pedigree with 
mul tiple members affected w ith GABEB (Hinmer 311d Wolff, 
1982) . ImmunoAuorescencc analys is of basement membran e zone 
components in this fa nu ly has recentl y been rcported (Pohla-Gubo 
et ai, 1995). T hc results show ed an absence ofBPAG2 expression in 
sevcral afi:ected individuals, implicating B PAG2 as the candidate 
gene fo r mutations in this family. T h e resul ts of mutational analysis 
in the present study dem on strate th at the affected mcmbers of th.is 
fa mily have a homozygo us de lction mutation in BPAG2 and 
provide evidence fo r the ro le of the lS0- kDa bulJo us pem ph.igoid 
antigen in adhesion o f basal keratinocytcs to epidermal basement 
111e nlbranc . 
MATERI ALS AND METH ODS 
C linic al T he n uclea r pedigree su bjected to analysis in this study is shown 
in F ig 1. 13 lood sam ples for gen ol11 ic DNA extractio ll were obtained from 
e igh t sib lings all d the ir m othe r; fo ur of the sib li ngs were affected w ith 
GABEI3. w hil e fo ur indi vid uals as we ll as the ir mother were clinicall y 
unaffected . An exte nsive pedigree of this f.1 11liiy. cn co tll pass in g several 
generatio ns , has p rev io usly becII published (H imller alld Wolff. 1982) . 
T his pedigree raises the possibi li ty of consangu ini ty in som e f:llnijy mem-
bers. 
Mut ation D etec t ion S trategy To search fo r l11u tations in the I3PAG2 
gene, DNA was isola ted fi'o m peri phera l blood b)' sta ll dard mcthods 
(Sambrook eI nl. 1989). For ampli ficatio n of all 56 kno wn exollS of the 
J3 PAG2 gc nc. p rim ers based 0 11 d lC Ran k ing intronic sequenccs were 
syn thesized (Garaliea CI nl, m'"lL,sc';pt ill preparation). Spccifi.ca Uy, amp h-
f, catio ll of the 390- bp exon con taining the hOJ1\oz)'gous deleaon m utaaon 
reported in Rl's"I IS (nucleotides 3872-426 1 ill the c DNA; GcnBank no . 
M9 1669; Giudice 1'1 nl. 1992) u tilized the fo llowing p ri mers: sellse pn mcr. 
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Figure 1. The pedigree of the family with GAllEB, Gellomic DNA 
samples were scudied from allmcmbers :lpare from those individuals marked 
by all ~I stcrisk. Carrier status is sho\·vu wjth respect to the 111utation 
delineated ill this stud y. 
5'-CAAGTCTTTCTCTCCACCGA-3'; ,lIlti-sell se p"imer, S' -CCA-
CAAACAAGAAAGCCAGT-3'. The size of the expected amplification 
product was 527 bp. For polymerase chuill re:lction (peR.) amplif,cation, 
- 250 Il g of genomic DNA was used ;IS template in ;I bulfct contain;ng 20 
pmol of each primer, 100 111M MgCI2 , 2 IllM of each of the four nucleotides, 
and 2.5 U ofTaq polymerase (Perkin Elmer Cetus). in a tota l volume of 50 
ILL The amplification conditions were: 94°C for 5 min, followed by 40 
cycles of 94°C for 45 S, 55°C for 45 s, n oc for 45 s, in an O ltlluGene 
thermal cycler (Marsh Scientific, Inc.) . Following amplification. aliquots of 
5 ILl were examined on 2% agamse gel dectropllGresis, and 3-10 ILl of the 
sample was prepared for heteroduplcx analysis (Keen of 01. 1991) on 
hydrol;nk gel according to the manufacturer's recommendations (MDE, 
J.T. Bakel', Inc.). Staining with ethidium bromide Was used to visualize the 
DNA bands. III .<ome cases. the aftected individual' s amplified DNA was 
Illixed with all equnl amoullr of ampliflCd DNA from an unaifectcd, 
unrelated indi vidual , to detect putative bomozygous mutations (G,)nguly "I 
aI, 1993). For the region demonstrating heterodup!ex formation (sec 
ReslJ!Js). the PCR. products were seq uenced for" heterozygous IIlUt:II1(. 11 
homozygous Illu tant, and an unrelated cOlltrol individual using an ADI 
autol11.atcd sequencer. 
Verification of the Mutation The lIlutation detected ill the DPAG2 
gene created a new restriction sit" for the endonuclease N Iall!. For 
verLf,c"tion of the presence of this mutation in genomic DNA, 10 fLl of the 
PCR. amplifIcation products from all fa lnily l11emb!!rs wcre suhjected to 
Nloill restriction enzyme d.igestion according to the manufacturer's recom-
mendations (N ew England BioLabs). The digestion products were electro-
phoresed On 3'Y., agarose gel. In addition to the melllb!!ts of the family 
studied. 50 unrelated healthy control subjects and 15 individuals with 
different forms of JEI3 were analyzed for the possible presence of this 
Inutation by restriction enzynlc digestion. 
RESULTS 
Identification of a homozygous 2-bp deletion within BPAG2 
Electrophoretic ana lysis showed a hete roduplex band, in addition to 
a homoduplex , in the mother and two unaffected offspring when 
the PCK amplification product corresponding to a 390-bp exon of 
BPAG2 was exa mined (Fig 2A). However, on ly a homoduplex 
band, similar to that noted in unre\;lted health y conerols, was 
detec ted in the affected individuals. This electrophoretic pattern 
suggested that the affected individuals were homozygous for a 
mutation carried by the mother. When amplified DNA &0111 the 
affected individuals was mixed with ampli.fied DNA isolated from 
unrelated healthy controls , h eteroduplcx analysis revealed a het-
eroduplex band in all four afFected individuals. This electrophoretic 
pattem was identica l to that noted with DNA fi 'om the mother 'llld 
the two clinically normal , apparently heterozygo us siblings (Fig 
2A). When DNA from the two other unaffected individuals, who 
did not initially demonstrate heteroduplex formation, was mixed 
with control DNA, no heteroduplex was formed. Collectively, 
these observations suggested that the clinically affected individuals 
were homozygous for a mutation , the mother and two un<tffected 
siblings were he terozygous carriers of the same mutation, and two 
unaffected siblings were not carriers of the mutation. 
The PCR amplifica tion products derived from the mother 
(heterozygous carrie r), an affected individu;rl, and an unre lated 
control individu al were subjected to direct nucleotide sequencing 
(Fig 2B). T he affected individual was homozygous for a 2-bp 
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deletion (TC). This mutation, designated 4003delTC, resulted in ~ 
frameshift and premature stop codon (TGA) 86 bp downstrea~ 
from the site of deletion. The unrelated control individual who di~ 
not revea l bands of aberrant mobility on heteroduplex analysis d.iq 
not show 'lily evidence for this genetic lesion . The mother \Va, 
shown to be a he terozygous carrier of this ll1utation, resulting in th~ 
framesh ift and premature termination codon in one of the aUele~ 
whi le the other a llele was normal (Fig 2B). 
T he mutation, 4003delTC, resulted in the gener:Jtion of a n ew 
restriction enzym e site for N falli. Amplification of the eX01\ 
con wining the mutation, together with flank.in g intronic sequences, 
resulted in the synth esis of a PCR product of 527 bp w hich UpOI) 
digestio n with N faTII ill normal controls yielded five b a.nds, 185, 
132, 1:l7, 83 , and 40 bp in size (Fig 2C) . In the presence of th '1 
4003delTC mutation, the IS5-bp band was further digest to tWG 
fragments, 151 and 32 bp in size. Examination of the PCR produc~ 
from affected individuals verified that the patients were indeeq 
homozygous for the presence of this mutation since no evidence fo~ 
the 185-bp band was noted (Fig 2C). T he results also confirmeq 
that the mother and two of the siblin gs were heterozygous ca rrier~ 
of the ll1utarion, wbi le two clinica lly unaffected m embers of th ~ 
fami ly, who did not demomtrate heteroduplex formation with o~ 
without added control DNA, did not ha ve this mutation . Exami 
nation of 50 clinically unaffected unrelated control individuals ,mq 
15 patients with different forms of epidermolysis bu\losa failed t(4 
reveal this mutation ill BPAG2, indicating that this genetic alter, 
ation is not common in the geJlcm l genc pool nor docs it represelJ ~ 
the molecular basis for JEB in the other patients studied thus far. 
DISCUSSION 
The re.wlts of this study h;1Ve delllonstr;,ted " specific 2-bp ddetiol"\ 
Illutation in the BPAG2 gcne, designated as 4003de1TC. Fo\t~ 
affected individlwls in the family were shown to be homozygo us fo~ 
the de letion, while the mother and two clinically unaffected sibling 
were heterozygous carners of this mutation. Two of the clinically 
unaffected individuals were also genotypica lly n o rmal with respect 
to this mutation. 
The 4003deITC mut;ltion results in a fi';ll11eshift .1l1d fortll'ltion o~ 
a downstream premature term.ination codon. This lllutation prob, 
ably results in inst;lbiljty of the lllRNA transcript, leading to a 
11l<lrkedly decreased produc tion of the protein (Urlaub c/ nJ, 1989; 
C heng el ai, 1990). In support of th is incerpretation is our recent 
demonstration of undetectable levels ofBPAG2 mRNA in cultured 
kenltinocytes of an individual w ho was a compound hetetozygot~ 
for diffcrent BPAG2 prema ture stop codon mutations in a similar 
region of the gene (McGrath ci ai, 1995a). Likewise, reduced 
BPAG2 rnRNA levels have been demonstrated in sevcral other 
patients with GABEB, although the specifi c mucations in the latter 
cases have not been disclosed Oonkman cl ai, 1995). 
Although it appears that most patients with GABEB have defecrs 
in BPAG2 Oonkman ct aI, 1995), this is not :1 uniform findin g. 
Recentl y, a patient with typical features of GABEB was found [0 
have mutations in LAMB3, the gene that encodes the b3 chai.n of' 
laminin 5 (M cGrath cl III, 1995b) . An interesting difference between 
this patient and the kindred exa mined in this study was apparent ill 
electron micrographs of [he skin. The patient with defective 
laminill 5 had rela tively intact he midesmosomcs (McGrath ef aI, 
1995b), whereas afFected individuals in this study and the previously 
reported GABEB patient with BPAG2 mutations, all h"d hypoplas-
tic hemidesmosom es that were markedl y redu ced in /lumber (Hint-
ncr and Wolff, 1982; McGrath cf ai, 1995a). This suggests that 
BPAG2 con tributes significantly to the structure of the inner and 
outer hemidesmosol1la l plaques. It also suggests that these morpho-
log ical findings may be useful in predictil1g [he underlying ca.ndi-
date gene for a particular patient with GAllED . 
Demonstration of a specific genetic lesion underlying the 
GABEB phenotype in this family bas several practi cal conse-
quences. First, screening of the remaining family m embers allow 
determination of the carrier state. Secondly, identification of rlti 
mutation now provides the means for DNA-based prenata l diag-
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Figure 2. Mutational analysis r eve a ls a homozygous 2-bp deletion in BPAG2 in the GABEB p a tients in t his fa.mily. A) H etcroduplc" analysis 
of a 5 27-bp segment o fJ3PAG 2 sho ws a hetcroduplc" band (» in add ition to a homodu ple" band in the m other (I-I) . but o n ly hom oduple" bands arc presen t 
in an affected individ ua l (ll- I) and a sibling (11-5). H o w e ver. when these samples arc assessed afte r m ix ing w ith co n tro l DNA , an addi tio nal he te roduple" 
band is p resent in the affected ind ivid ual (ll-l + r), but no t in th e unaffec ted sibling (1l-5+c) . In the co ntro l sample (r). only a llOm odup lc" band is detected . 
B) D irec t nucleotide sequencing shows the w ild-type sequence fo r part of the PC R. product in the top panel. Seq uence from an a fFec ted ind ivid ual (II-I ) 
revea ls a ho m ozygo us 2- bp deleti o n of T C (/Il iddle }Jfl llel); these nucleotides arc depicted by the two arrowheads in the wi ld- t)'pe seq uence. Seq uencing o f 
DNA frol11 the 1lI0 ther (I - I) dem o nstrates a fi'am eshift at the site of the arrow (/oll'el' pnlld) d ue to a hete rozygo us 2- bp deletion o n o ne all el e . C) V erifi catio n 
of the mu ta tio n by restrictio n endo nuclease digestio n the enzyme I InllI , w hich c re:ltes a new restri ct io n site in the llIu ta n t a lle le . [" the contro l sample (r) 
an d the unaffected sibling (11-5), the PC R. produ ct is cut in to di gestio n products '185. 132. 87, 83. an d 40 bp in size. In the afl'ected indi vid ual (11-1) , the 185- bp 
band is further d igested into 151 - and 32- bp products. In the m other (1 - I) bo th the 185- and '1 52-hI' bands arc v isib le , consiste n t w ith a hete rozygous can;er 
of th e m utation . 
nosis in pregnancies at ri sk (Christia no and U itto , 1993). T he 
importance of these co nsideratio ns is em phas ized by the fa ct that 
seve ral of the prev iously affec ted individuals in this fa I11il y died soon 
after birth, according to the original clinical report (Hintner and 
Wolff, 1982) . Finally, knowledge o f the specific mutation in 
BPAG2 gene in this famil y allo ws the futu re development of gene 
rep lacement therapy (Taichman , 1994). 
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